Taiwan Dialysis Market

Plastic Optic Fiber Market Report Thumbnail

Taiwan Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), by Dialysis Modality (Conventional Dialysis, Short Daily Dialysis, and Nocturnal Dialysis), by Product Type (Equipment, Consumables, and Services), and by End-user (Hospitals, Dialysis Centers, Homecare, and Ambulatory Surgical Centers)– Opportunity Analysis and Industry Forecast, 2024–2030

Industry: Healthcare | Publish Date: 06-Dec-2024 | No of Pages: 122 | No. of Tables: 77 | No. of Figures: 50 | Format: PDF | Report Code : HC1273

  • Facebook
  • Linkedin
  • Whatsapp

Taiwan Dialysis Market Overview

The Taiwan Dialysis Market size was valued at USD 203.6 million in 2023 and is predicted to reach USD 317.5 million by 2030, with a CAGR of 6.1% from 2024 to 2030.

The dialysis market encompasses the global industry focused on providing treatments and services for patients with kidney failure or severe kidney dysfunction. It includes a wide range of components such as medical devices including dialysis machines and dialyzers, which are essential for performing hemodialysis and peritoneal dialysis.

The market also covers pharmaceuticals that help manage complications associated with kidney failure, including anemia treatments and phosphate binders. Dialysis services comprise both in-center treatments conducted in specialized clinics and home dialysis options, which allow patients to manage their care in the comfort of their own homes. Technological innovations, such as digital health solutions for patient management and portable dialysis devices, are increasingly transforming patient care.

Growing Number of Chronic Kidney Disease in Taiwan Boosts the Market Growth

The increasing prevalence of chronic kidney disease (CKD) in Taiwan, driven by the rising rates of diabetes, hypertension, and lifestyle changes drives the demand for dialysis treatments. As reported by BenQ Dialysis, in 2023, approximately 2.5 million individuals in Taiwan are affected by some form of kidney disease, with over 90,000 people currently undergoing dialysis treatment. As more individuals require therapy, healthcare facilities are expanding their services to meet demand, that in turn boosts the renal dialysis market growth.

 

Increasing Ageing Population Boosts the Demand for Dialysis Treatment in Taiwan

The growing geriatric population in Taiwan is a crucial factor propelling the expansion of the dialysis market, as elderly individuals are particularly vulnerable to CKD. As the risk of CKD rises with age, the demand for dialysis treatments is expected to grow in Taiwan, boosting the growth of the market.

The latest report from the Global Taiwan Institute indicates that the proportion of those aged 65 and above in Taiwan is projected to rise to 19% between 2019 and 2050. This significant demographic shift underscores the increasing healthcare challenges posed by an aging population, necessitating enhanced medical services, including dialysis.

 

The Rising Prevalence of Diabetes in Taiwan Boosts Market Expansion

The rising number of diabetes patients in Taiwan is significantly fueling the country's dialysis market, as individuals with diabetes face a higher risk of kidney-related complications, necessitating regular dialysis treatment for health maintenance.

According to the International Diabetes Federation (IDF), the number of diabetes patients in Taiwan was approximately 24.5 million in 2021, and it is projected to reach 30.3 million by 2045, reflecting a 23.7% increase over 24 years. This growing prevalence of diabetes is driving the demand for advanced dialysis solutions and comprehensive renal care, contributing to the expansion of the dialysis market in Taiwan.

Shortage of Skilled Healthcare Professionals Restricts Market Growth

The shortage of skilled healthcare professionals, including nephrologists and dialysis nurses, presents a significant challenge to Taiwan dialysis market growth. This lack of trained personnel directly impacts the availability and quality of dialysis services, as a limited number of professionals struggle to meet the increasing demand for treatment. Consequently, the absence of experienced staff results in delays in treatment, leading to a decline in overall patient care quality, hindering the market's growth.

Advancements in Dialysis Technology Create Ample Growth Opportunities for the Market

Advancements in kidney dialysis technology, particularly the development of portable dialysis devices, are expected to create significant growth opportunities for the market in the coming years. These innovations enable treatments in various settings, such as homes and workplaces, thereby enhancing patient enterprise mobility and independence while reducing time spent in clinics.

Healthcare providers are able to effectively monitor patients remotely, utilizing intuitive interfaces and remote monitoring capabilities that minimize the need for in-person visits. As a result, the evolution of portable kidney dialysis technology presents substantial opportunities for improving treatment outcomes and fostering patient independence, creating significant opportunities in the Taiwan dialysis market demand.

By Type, Hemodialysis Holds the Largest Share in Taiwan Dialysis Market

Hemodialysis dominates the Taiwan dialysis market share, as it is considered the standard treatment for end-stage renal disease (ESRD), supported by extensive clinical evidence affirming its efficacy and safety.

Moreover, the robust network of dialysis centers in Taiwan ensures easy accessibility to hemodialysis to patients with CKDs, hemodialysis is known for its rapid effectiveness in removing waste products from the blood, improving patient outcomes and managing complications.

By End-User, Homecare is Anticipated to Show Highest Growth in The Future

The homecare segment is anticipated to show the Taiwan dialysis market trends, with a compound annual growth rate (CAGR) of 8.3% from 2024 to 2030. This growth due to the increasing number of patients adopting home-based dialysis treatment for convenience and improved quality of life.

The rising geriatric population, particularly those with chronic kidney disease, further drives this trend, as older patients often prefer homecare options. Additionally, advancements in dialysis technology along with the growing awareness & acceptance of home dialysis options among healthcare IT providers and patients is expected to contribute significantly to the market expansion in the coming years.

 

Competitive Landscape

Several key market players operating in the Taiwan dialysis industry include Fresenius Medical Care, Baxter International, Inc., B. Braun, Nikkiso Co. Ltd., Medtronic plc, HI-CLEARANCE INC, Becton, Dickinson and Company, BenQ Dialysis Technology Corp, and Bioteque Corporation, Excelsior Medical Co., Ltd. among others.

Taiwan Dialysis Market Key Segment

By Type

  • Hemodialysis

    • Conventional Hemodialysis 

    • Hemofiltration

    • On-line Hemodiafiltration 

    • Off-line Hemodiafiltration

  • Peritoneal Dialysis

By Dialysis Modality

  • Conventional Dialysis

  • Short Daily Dialysis

  • Nocturnal Dialysis

By Product Type

  • Equipment

    • Dialysis Machines

    • Dialyzers

    • Bloodlines

    • Other Equipment

  • Consumables

    • Dialysis Fluids

    • Catheters

    • Dialysis Access Devices

    • Other Consumables

  • Services

    • Dialysis Treatment Services

    • Maintenance and Support Services

By End-user

  • Hospitals

  • Dialysis Centers

  • Homecare

  • Ambulatory Surgical Centers

Key Players

  • Fresenius Medical Care

  • Baxter International, Inc.

  • B. Braun

  • Nikkiso Co. Ltd.

  • Medtronic plc

  • HI-CLEARANCE INC

  • Becton, Dickinson and Company

  • BenQ Dialysis Technology Corp

  • Bioteque Corporation

  • Excelsior Medical Co., Ltd.

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 203.6 Million

Revenue Forecast in 2030

USD 317.5 Million

Growth Rate

CAGR of 6.1% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Million (USD)

Growth Factors

  • The growing CKD in Taiwan boosts the growth of the market

  • Increasing ageing population drives the market growth

  • Rising prevalence of diabetes in Taiwan creates market expansion

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Bar chart Pie chart Pie chart

Frequently Asked Questions

According to Next Move Strategy Consulting, in 2023, the Taiwan dialysis market was valued at USD 203.6 million and is projected to reach USD 317.5 million by 2030, growing at a CAGR of 6.1% from 2024 to 2030.

Key factors include the growing prevalence of chronic kidney disease (CKD), aging population, and the rising number of diabetes patients, all of which increase the demand for dialysis treatments.

The dialysis market includes medical devices such as dialysis machines and dialyzers, pharmaceuticals to manage kidney disease complications, and dialysis services (both in-center and home dialysis).

Hemodialysis holds the largest market share, accounting for over 60% of the market.

Key players in the Taiwan dialysis market include Fresenius Medical Care, Baxter International, Inc., B. Braun, Nikkiso Co. Ltd., Medtronic plc, HI-CLEARANCE INC, Becton, Dickinson and Company, BenQ Dialysis Technology Corp, and Bioteque Corporation.

Download Free Sample

Please Enter Full Name

Please Enter Valid Email ID

Please enter Country Code and Phone No

Please enter message

popular
$2,575
$1,575
$3,875
$2,975

This website uses cookies to ensure you get the best experience on our website. Learn more